Stock data
Rapport Therapeutics, Inc. (RAPP)
Rapport Therapeutics, Inc. (RAPP) reported net income of -US$111.48M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$125.10M | -US$111.48M | — |
| 2024 | — | — | -US$83.06M | -US$78.31M | — |
| 2023 | — | — | -US$36.18M | -US$34.79M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.00M | -US$56.62M | — |
| 2026-03-31 | US$20.00M | -US$19.86M | — |
| 2025-12-31 | — | -US$33.76M | — |
| 2025-09-30 | — | -US$26.93M | — |
| 2025-06-30 | US$0.00M | -US$26.73M | — |
| 2025-03-31 | US$0.00M | -US$24.06M | — |
| 2024-12-31 | — | -US$19.98M | — |
| 2024-09-30 | — | -US$17.54M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.